Patients with asthma and chronic obstructive pulmonary disease (COPD) routinely switch from pressurized metered-dose inhalers (pMDIs ... Please see the original reference for a full list of authors’ ...
These are typically drugs that may be especially harmful and, in some cases, fatal with just one dose if they are used by someone other than the person for whom the medicine was prescribed. You can ...
Sanofi SNY and partner Regeneron REGN announced that the FDA has approved their blockbuster drug, Dupixent, for its sixth ...
The Red Sox placed Kenley Jansen (shoulder) on the 15-day injured list on Sept. 23, ending his season. Expect Chris Martin and Justin Slaten to share the closer duties. (September 24) Ben Joyce ...
Dupixent is now cleared for use as an add-on maintenance treatment for adults with a certain kind of chronic obstructive pulmonary disease, or COPD, that can’t be controlled with other medications.
A year ago, life for many people in the UK with attention deficit hyperactivity disorder (ADHD) became unpredictable and disorientating as their medications ... a published list of currently ...
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.
The drug was cleared for use in adults whose COPD symptoms aren’t under control and whose disease is driven by eosinophils, a type of immune cell that can contribute to inflammation. There are ...
This approval was based on results from the phase 3 BOREAS (NCT03930732) and NOTUS (NCT04456673) trials, which demonstrated that dupilumab can significantly reduce COPD exacerbations. 2 The first ...
You’ve reached your account maximum for followed topics. A Genshin Impact player has created a chart revealing the 5-star waiting list for Version 5.1 Shenhe ...
The Central Drug Standards Control Organisation (CDSCO) has flagged more than 50 drugs for common conditions like high blood pressure and acid reflux as substandard. This includes batches from ...